Journal
NEUROREPORT
Volume 12, Issue 5, Pages 1067-1072Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200104170-00040
Keywords
axotomy; BDNF; facial nerve; pharmacokinetics; sciatic nerve
Categories
Ask authors/readers for more resources
Brain-derived neurotrophic factor (BDNF) belongs to the neurotrophin family and has been shown to be a potent and effective trophic factor for motor neurons and other neurons of the peripheral and central nervous. Little is known, however, about the relationship between the efficacy and pharmacokinetics of s.c. administered BDNF. In this study, the efficacy of BDNF on motor neuron protection in sciatic or facial nerve axotomy models was examined and compared with the concommitant concentrations of BDNF in plasma. Delayed treatment (started at I week after surgery) of BDNF was also shown to retard choline acetyltransferase reduction in sciatic nerve axotomy models. NeuroReport 12:1067-1072 (C) 2001 Lippincott Williams & Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available